Product Pipeline

Accelerating Biopharmaceutical Development





The Pfënex Expression Technology™ platform uniquely positions Pfenex to address production of proteins to serve a wide range of markets and fulfill an unmet need for rapid reliable protein production development. The Pfenex product pipeline currently contains biosimilar proteins advantaged over innovator proteins through improvements in expression titer and product quality, as well as novel vaccines to address existing and emerging disease and  meet increasingly stringent standards for speed of delivery and product quality.